Back

Dopamine controls the Sensitivity to Manganese induced Dopaminergic neurotoxicity in Caenorhabditis elegans

Raj, V.; Thekkuveettil, A.

2024-10-28 pharmacology and toxicology
10.1101/2024.10.23.619952 bioRxiv
Show abstract

Manganism, a disease with characteristic degeneration of dopamine neurons, has distinct aetiology and clinical manifestations, striking similarities with Parkinsons Disease (PD). Environmental exposure to manganese (Mn) is one of the risk factors for the occurrence of PD. The definitive role of dopamine (DA) in Mn mediated neurodegeneration, and its developmental impact has not been well studied. To understand the pathways involved in Mn-induced neurotoxicity, we used C. elegans as the model system. Our results showed that adult worms treated with 50 and 100 mM MnCl2 significantly increased DA neurodegeneration. L1 larvae spared without neurodegeneration when treated with MnCl2 alone showed a significant increase in neurodegeneration (>50%) when MnCl2 exposure was given after DA pretreatment. However, both adult and larval exposure to MnCl2 demonstrated significant toxicity by reducing the survival rate. In adult worms, 100 mM MnCl2 treatment after DA pretreatment further elevated the percentage of neurodegeneration. The Mn or DA alone exposed adult worms showed recovery of neuronal dopamine function within 24 hours, although exogenous DA and Mn treated worms showed prolonged behavioural defects. Cat-2 mutants, without DA, were resistant to Mn mediated neurodegeneration. In contrast, Cat-2 overexpressing strain displayed severe neurodegeneration at lower concentrations of MnCl2 (50 mM). Our results on biochemical, behavioural and genetic assays proved endogenous/exogenous DA level controls the sensitivity to Mn induced dopaminergic neurotoxicity.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 12%
15.4%
2
NeuroToxicology
14 papers in training set
Top 0.1%
12.9%
3
Neurochemistry International
10 papers in training set
Top 0.1%
9.1%
4
Scientific Reports
3612 papers in training set
Top 7%
8.0%
5
European Journal of Pharmacology
15 papers in training set
Top 0.1%
4.4%
6
Parkinsonism & Related Disorders
25 papers in training set
Top 0.2%
3.5%
50% of probability mass above
7
Frontiers in Pharmacology
111 papers in training set
Top 0.8%
3.2%
8
International Journal of Molecular Sciences
494 papers in training set
Top 5%
2.5%
9
Heliyon
152 papers in training set
Top 3%
1.9%
10
British Journal of Pharmacology
40 papers in training set
Top 0.3%
1.8%
11
Gene
46 papers in training set
Top 0.8%
1.8%
12
Behavioural Brain Research
77 papers in training set
Top 0.7%
1.8%
13
ACS Chemical Neuroscience
67 papers in training set
Top 0.6%
1.8%
14
PLOS Neglected Tropical Diseases
466 papers in training set
Top 3%
1.8%
15
Toxicological Sciences
41 papers in training set
Top 0.3%
1.7%
16
Biology Open
156 papers in training set
Top 2%
1.1%
17
Molecular Neurobiology
53 papers in training set
Top 1%
1.1%
18
European Journal of Neuroscience
189 papers in training set
Top 3%
1.1%
19
Biomedicine & Pharmacotherapy
42 papers in training set
Top 1%
0.9%
20
Neurobiology of Disease
148 papers in training set
Top 3%
0.9%
21
Experimental Neurology
61 papers in training set
Top 1%
0.9%
22
Free Radical Biology and Medicine
36 papers in training set
Top 0.7%
0.9%
23
Acta Tropica
13 papers in training set
Top 0.5%
0.9%
24
Neuroscience Letters
32 papers in training set
Top 0.5%
0.9%
25
Biomedicines
67 papers in training set
Top 3%
0.9%
26
Environmental Pollution
37 papers in training set
Top 1%
0.9%
27
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.3%
0.6%
28
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.9%
0.6%
29
Biochemical Pharmacology
20 papers in training set
Top 0.5%
0.6%